{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:01:02Z","timestamp":1766023262895,"version":"3.48.0"},"reference-count":25,"publisher":"e-Century Publishing Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/xids4307","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:21:39Z","timestamp":1737519699000},"page":"330-337","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of dipyridamole plus IVIG and aspirin on anti-platelet aggregation factors and inflammatory factors in children with Kawasaki disease"],"prefix":"10.62347","volume":"17","author":[{"given":"Lijiang","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT and Pahl E; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017; 135: e927-e999.","DOI":"10.1161\/CIR.0000000000000484"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/ped.14326","article-title":"Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)","volume":"62","author":"Kobayashi","year":"2020","unstructured":"Kobayashi T, Ayusawa M, Suzuki H, Abe J, Ito S, Kato T, Kamada M, Shiono J, Suda K, Tsuchiya K, Nakamura T, Nakamura Y, Nomura Y, Hamada H, Fukazawa R, Furuno K, Matsuura H, Matsubara T, Miura M and Takahashi K. Revision of diagnostic guidelines for Kawasaki disease (6th revised edition). Pediatr Int 2020; 62: 1135-1138.","journal-title":"Pediatr Int"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y and Nakamura Y. Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017-2018. J Pediatr 2020; 225: 23-29, e2.","DOI":"10.1016\/j.jpeds.2020.05.034"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/INF.0000000000000953","article-title":"Kawasaki disease in Germany: a prospective, population-based study adjusted for underreporting","volume":"35","author":"Jakob","year":"2016","unstructured":"Jakob A, Whelan J, Kordecki M, Berner R, Stiller B, Arnold R, von Kries R, Neumann E, Roubinis N, Robert M, Grohmann J, Hohn R and Hufnagel M. Kawasaki disease in Germany: a prospective, population-based study adjusted for underreporting. Pediatr Infect Dis J 2016; 35: 129-134.","journal-title":"Pediatr Infect Dis J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","article-title":"Kawasaki disease: pathophysiology and insights from mouse models","volume":"16","author":"Noval Rivas","year":"2020","unstructured":"Noval Rivas M and Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol 2020; 16: 391-405.","journal-title":"Nat Rev Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"101516","DOI":"10.1016\/j.ppedcard.2022.101516","article-title":"A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children","volume":"65","author":"Wessels","year":"2022","unstructured":"Wessels PA and Bingler MA. A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children. Prog Pediatr Cardiol 2022; 65: 101516.","journal-title":"Prog Pediatr Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"110263","DOI":"10.1016\/j.mehy.2020.110263","article-title":"Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2","volume":"144","author":"Yeo","year":"2020","unstructured":"Yeo WS and Ng QX. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2. Med Hypotheses 2020; 144: 110263.","journal-title":"Med Hypotheses"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome","volume":"324","author":"Newburger","year":"1991","unstructured":"Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324: 1633-1639.","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.21037\/tp-20-482","article-title":"The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis","volume":"10","author":"Li","year":"2021","unstructured":"Li D, Li X, Dou W and Zheng Y. The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis. Transl Pediatr 2021; 10: 1294-1306.","journal-title":"Transl Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00246-014-1016-1","article-title":"Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database","volume":"36","author":"Moffett","year":"2015","unstructured":"Moffett BS, Syblik D, Denfield S, Altman C and Tejtel-Sexson K. Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database. Pediatr Cardiol 2015; 36: 374-378.","journal-title":"Pediatr Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0049-3848(83)90356-0","article-title":"Mechanism of action of dipyridamole","volume":"4","author":"Harker","year":"1983","unstructured":"Harker LA and Kadatz RA. Mechanism of action of dipyridamole. Thromb Res Suppl 1983; 4: 39-46.","journal-title":"Thromb Res Suppl"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.2174\/1381612826666201001125604","article-title":"Potential therapeutic benefits of dipyridamole in COVID-19 patients","volume":"27","author":"Aliter","year":"2021","unstructured":"Aliter KF and Al-Horani RA. Potential therapeutic benefits of dipyridamole in COVID-19 patients. Curr Pharm Des 2021; 27: 866-875.","journal-title":"Curr Pharm Des"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"120334","DOI":"10.1016\/j.jns.2022.120334","article-title":"Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke","volume":"441","author":"ST","year":"2022","unstructured":"Lim ST, Murphy SJX, Murphy SM, Coughlan T, O’Neill D, Tierney S, Egan B, Collins DR, McCarthy AJ, Lim SY, Smith DR, Cox D and McCabe DJH. Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke. J Neurol Sci 2022; 441: 120334.","journal-title":"J Neurol Sci"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Huang HY, Lu TW, Liang HL, Hsu WH, Sung YW and Lee MY. Antiplatelet agents aspirin and dipyridamole, and the risk of different carcinoma in patients with type 2 diabetes mellitus: a Taiwan retrospective cohort study. Medicine (Baltimore) 2022; 101: e30468.","DOI":"10.1097\/MD.0000000000030468"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.21037\/tp-21-299","article-title":"Efficacy evaluation and mechanical study of short- and long-term antithrombotic therapy for Kawasaki disease","volume":"10","author":"Hao","year":"2021","unstructured":"Hao J, Wang H, Chen J, Li B, Zhang H and Zhang Y. Efficacy evaluation and mechanical study of short- and long-term antithrombotic therapy for Kawasaki disease. Transl Pediatr 2021; 10: 1883-1889.","journal-title":"Transl Pediatr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00431-019-03368-x","article-title":"Effectiveness of antiplatelet therapy for Kawasaki disease: a systematic review","volume":"178","author":"Tanoshima","year":"2019","unstructured":"Tanoshima R, Hashimoto R, Suzuki T, Ishiguro A and Kobayashi T. Effectiveness of antiplatelet therapy for Kawasaki disease: a systematic review. Eur J Pediatr 2019; 178: 947-955.","journal-title":"Eur J Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11908-021-00746-1","article-title":"2021 Update on the clinical management and diagnosis of Kawasaki disease","volume":"23","author":"Zhu","year":"2021","unstructured":"Zhu F and Ang JY. 2021 Update on the clinical management and diagnosis of Kawasaki disease. Curr Infect Dis Rep 2021; 23: 3.","journal-title":"Curr Infect Dis Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.21037\/tp-21-74","article-title":"Effectiveness and safety of dual antiplatelet therapy in coronary aneurysms caused by Kawasaki disease in children: study protocol for a multicenter randomized clinical trial","volume":"10","author":"Li","year":"2021","unstructured":"Li D, Chen X, Li X, Yuan Y, Jin H, Liu G, Zhang H and Xie G. Effectiveness and safety of dual antiplatelet therapy in coronary aneurysms caused by Kawasaki disease in children: study protocol for a multicenter randomized clinical trial. Transl Pediatr 2021; 10: 1914-1923.","journal-title":"Transl Pediatr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5137874","DOI":"10.1155\/2022\/5137874","article-title":"Efficacy of gamma globulins in children with Kawasaki disease and factors influencing Children’s short-term prognosis","volume":"2022","author":"Sun","year":"2022","unstructured":"Sun H, Lu H and Wu Y. Efficacy of gamma globulins in children with Kawasaki disease and factors influencing Children’s short-term prognosis. Comput Math Methods Med 2022; 2022: 5137874.","journal-title":"Comput Math Methods Med"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Su X, Wang P and Li B. A prospective study on different doses of gammaglobulin plus aspirin in the pediatric Kawasaki disease and the impacts on CRP and WBC levels. Klin Padiatr 2024; [Epub ahead of print].","DOI":"10.1055\/a-2373-0867"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Balakumar P, Nyo YH, Renushia R, Raaginey D, Oh AN, Varatharajan R and Dhanaraj SA. Classical and pleiotropic actions of dipyridamole: not enough light to illuminate the dark tunnel? Pharmacol Res 2014; 87: 144-150.","DOI":"10.1016\/j.phrs.2014.05.008"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s43042-022-00354-1","article-title":"Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail","volume":"23","author":"Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E and Batiha GE. Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail. Egypt J Med Hum Genet 2022; 23: 140.","journal-title":"Egypt J Med Hum Genet"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Ramakers BP, Riksen NP, Stal TH, Heemskerk S, van den Broek P, Peters WH, van der Hoeven JG, Smits P and Pickkers P. Dipyridamole augments the antiinflammatory response during human endotoxemia. Crit Care 2011; 15: R289.","DOI":"10.1186\/cc10576"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fped.2020.00187","article-title":"Risk factors of intravenous immunoglobulin resistance in children with Kawasaki disease: a meta-analysis of case-control studies","volume":"8","author":"Liu","year":"2020","unstructured":"Liu G, Wang S and Du Z. Risk factors of intravenous immunoglobulin resistance in children with Kawasaki disease: a meta-analysis of case-control studies. Front Pediatr 2020; 8: 187.","journal-title":"Front Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1160\/TH12-05-0326","article-title":"Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes","volume":"109","author":"Massaro","year":"2013","unstructured":"Massaro M, Scoditti E, Carluccio MA, Pellegrino M, Calabriso N, Storelli C, Martines G and De Caterina R. Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes. Thromb Haemost 2013; 109: 280-289.","journal-title":"Thromb Haemost"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/1\/ajtr0161347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:04Z","timestamp":1766022964000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/1\/ajtr0161347.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/xids4307","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}